OptiNose Inc.
🏢 View company profile →7Patents
7Active
7Granted
44Portfolio score
Filing activity: Feb 14, 2007 → Jul 2, 2021 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11690969B2 | Delivery of gases to the nasal airway | Human Necessities | 0 | Active |
| US12083270B2 | Delivery device and method | Human Necessities | 0 | Active |
| US11571531B2 | Powder delivery devices | Human Necessities | 0 | Active |
| US11602603B2 | Nasal delivery devices | Human Necessities | 0 | Active |
| US11554229B2 | Nasal administration | Human Necessities | 0 | Active |
| US11707586B2 | Intranasal administration | Human Necessities | 0 | Active |
| US11730904B2 | Intranasal administration | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.